Each of the three markets discussed in the report has a unique set of factors affecting its growth profile. In terms of the market drivers, for example, the bone graft market is seeing increasing adoption rate as newly trained surgeons are entering the workforce. The viscosupplementation market continues to bring improved products along with expanded indications. The bone stimulator market maintains a high clinical success rate and is therefore also increasing its adoption rate.
Similarly, each market has its own set of limiters. For example, the growth in the bone graft substitute market is challenged by the lack of structure around tissue donation systems, which limits the supply side of the market. The viscosupplementation market is facing an unfavorable reimbursement structure which prevents it from reaching adoption rates observed in other developed countries. The bone stimulator market is being limited by the influx of new devices with a lower price tag and a growing market share, thus driving overall ASP down. Each market also has its own ongoing trend.
In the bone graft market there is an ongoing shift from using autografts towards substitutes due to the preference for less invasive procedures in general. In the viscosupplementation market the single-injection market continues to take from the three-injection market. Finally, in the bone stimulator market there is a trend towards multi-user devices in lights of the entrance of new products.
Key Topics Covered:
1. Executive Summary Canadian Orthopedic Biomaterials Market Top Canadian Orthopedic Biomaterials Companies Market Developments
2. Research Methodology
3. Canadian Orthopedic Biomaterials Market Overview 3.1 Market Overview 3.2 Trend Analysis 3.3 Currency Exchange Rate 3.4 Mergers And Acquisitions